FORM - 2
THE PATENTS ACT, 1970
(39 of 1970)
&
The Patents Rules, 2003
COMPLETE SPECIFICATION
(See Section 10 and Rule 13)
SKIN LIGHTENING AGENTS, COMPOSITIONS AND METHODS


HINDUSTAN UNILEVER LIMITED, a company incorporated under the Indian Companies Act, 1913 and having its registered office at Hindustan Lever House, 165/166, Backbay Reclamation, Mumbai -400 020, Maharashtra, India

The following specification particularly describes the invention and the manner in which it is to be performed



WO 2007/112855 * l PCT/EP2007/002444
-1-
SKIN LIGHTENING AGENTS, COMPOSITIONS AND METHODS
The invention relates to cosmetic compositions and methods using 4-hydroxyphenylpyruvate and derivative compounds as skin tightening agents. 5
Many people are concerned with the degree of pigmentation of their skin. For example, people with age spots or freckles may wish such pigmented spots to be less pronounced. Others may wish to reduce the skin darkening caused by exposure to sunlight or to lighten their natural skin color. To meet this need, many attempts have been made to 10 develop products that reduce the pigment production in the melanocytes. However, the substances identified thus far tend to have either low efficacy or undesirable side effects, such as, for example, toxicity or skin irritation. Therefore, there is a continuing need for new cosmetic skin lightening agents, with improved overall effectiveness.
15 Applicants have now discovered that 4-hydroxyphenylpyruvate and derivative compounds deliver skin lightening benefits. The general chemical formulas and structures of these compounds are discussed in more detail hereinbelow. The 4-hydroxyphenylpyruvate and derivative compounds have been found to be cosmetically effective and possibly less irritating to the skin. These compounds of the present invention have not been used in
20 cosmetics, nor have they been used, specifically, for lightening skin. The 4-
hydroxyphenylpyruvate is available from Sigma-Aldrich.
SUMMARY OF THE INVENTION
The use of compounds of the general formula I and derivatives thereof, and compositions 25 including same, delivers skin lightening benefits with potential reduced irritation. The present invention provides a cosmetic composition and method of skin lightening using a composition comprising, in addition to a cosmetically acceptable vehicle, about O.000001 to about 50 % of a compound of general formula I or derivatives thereof:
(I)

30

WO 2007/112855 ' PCT/EP2007/002444
-2-
wherein each R, independently, represents a hydrogen atom, Ct-C4 acyl group, or Cf-C4
alkyl group.
5 Preferably at least one R represents hydrogen. More preferably each R is hydrogen as represented by the 4-hydroxyphenylpyruvate (or para-hydroxyphenylpyruvate, abbreviated as p-hydroxyphenylpyruvate) compound of formula II:
01)

10
Further skin benefit agents may be included in the inventive cosmetic compositions. Organic and inorganic (e.g. micronized metal oxide) sunscreens may also be included.
15 The inventive cosmetic compositions and methods have effective skin lightening properties and may be less irritating to the skin.
DETAILED DESCRIPTION OF THE INVENTION
As used herein, the term "cosmetic composition" is intended to describe compositions for 20 topical application to human skin.
The term "skin" as used herein includes the skin on the face, neck, chest, back, arms, axilla, hands, legs, and scalp.
25 Except in the examples, or where otherwise explicitly indicated, all numbers in this description indicating amounts of material or conditions of reaction, physical properties of materials and/or use are to be understood as modified by the word "about". All amounts are by weight of the composition, unless otherwise specified.

WO 2007/112855

PCT/EP2007/002444

-3-
It should be noted that in specifying any range of concentration, any particular upper concentration can be associated with any particular lower concentration.
The term "comprising" is used herein in its ordinary meaning and means including, made up of, composed of, consisting and/or consisting essentially of. In other words the term is defined as not being exhaustive of the steps, components, ingredients, or features to which it refers.

10

SKIN LIGHTENING AGENTS
The invention is concerned with the use of compounds of general formula I and derivatives thereof, shown below, and compositions including same, as skin cosmetic agents, particularly as skin lightening agents. A particular advantage of the inventive compositions and methods is that compounds of general formula I and derivatives thereof can be less irritating to the skin than known skin lightening compounds,

15
(I)

wherein each R, independently, represents a hydrogen atom, Cr-C4 acyl group, or C1-C4 20 alkyl group.
Preferably at least one R represents hydrogen. More preferably each R represents hydrogen, as represented by the 4-hydroxyphenylpyruvate compound of formula II:
(ID


30

WO 2007/112855 ' PCT/EP2007/002444
-4-
The inventive compounds may be used for reducing overall skin pigmentation and the reduction of discrete hyperpigmentation, such as blemishes and freckles, as well as for reducing the irritation associated with irritating skin benefit agents, such as retinol.
5 Further skin benefit agents may be included in the inventive cosmetic compositions. Organic and inorganic sunscreens may also be included.
The inventive cosmetic compositions and methods have effective skin lightening properties and may be less irritating to the skin.
10
The compositions generally contain about 0.000001 to about 50 % of compounds of general formula i. Compounds of formula II are preferred. The amount of the compound of general formula I or formula II is preferably in the range of about 0.00001 % to about 10 %, more preferably about 0.001 to about 7 %, most preferably from 0.01 to about 5 %,
15 of the total amount of a cosmetic composition.
OPTIONAL SKIN BENEFIT AGENTS
Preferred cosmetic compositions are those suitable for the application to human skin according to the method of the present invention, which optionally, but preferably, include 20 a further skin benefit agent.
Suitable additional skin benefit agents include anti-aging, wrinkle-reducing, skin whitening, anti-acne, and sebum reduction agents. Examples of these include alpha-hydroxy acids, beta-hydroxy acids, polyhydroxy acids, betulinic acid, hyaluronic acid, 25 hydroquinone, t-butyl hydroquinone, vitamin B derivatives, vitamin C derivatives, allantoin (a placenta extract), dioic acids, retinoids and resorcinol derivatives.
COSMETICALLY ACCEPTABLE CARRIER
The cosmetically acceptable vehicle may act as a distant, dispersant or carrier for the 30 skin benefit ingredients in the composition, so as to facilitate their distribution when the composition is applied to the skin.
The vehicle may be aqueous, anhydrous or an emulsion. Preferably, the compositions are aqueous or an emulsion, especially water-in-oil or oil-in-water emulsion, preferably oil 35 in water emulsion. Water when present will be in amounts which may range from 5 to 99%, preferably from 20 to 70%, optimally between 40 and 70% by weight.

WO 2007/112855 PCT/EP2007/002444
-5-
Besides water, relatively volatile solvents may also serve as carriers within compositions of the present invention. Most preferred are monohydric C1-C3 alkanols. These include ethy! alcohol, methyl alcohol and isopropyl alcohol. The amount of monohydric alkanol may range from 1 to 70%, preferably from 10 to 50%, optimally between 15 to 40% by 5 weight.
Emollient materials may also serve as cosmetically acceptable carriers. These may be in the form of silicone oils and synthetic esters. Amounts of the emollients may range anywhere from 0.1 to 50%, preferably between 1 and 20% by weight.
10
15
20
Silicone oils may be divided into the volatile and non-volatile variety. The term "volatile" as used herein refers to those materials which have a measurable vapor pressure at ambient temperature. Volatile silicone oils are preferably chosen from cyclic or linear polydimethylsiloxanes containing from 3 to 9, preferably from 4 to 5, silicon atoms. Linear volatile silicone materials generally have viscosities less than about 5 centistokes at 25°C while cyclic materials typically have viscosities of less than about 10 centistokes. Non¬volatile silicone oils useful as an emollient material include polyalkyl sitoxanes, polyalkylaryl siloxanes and polyether sifoxane copolymers. The essentially non-volatile polyalkyl siloxanes useful herein include, for example, polydimethyi siloxanes with viscosities of from about 5 to about 25 million centistokes at 25°C. Among the preferred non-volatile emollients useful in the present compositions are the polydimethyi siloxanes having viscosities from about 10 to about 400 centistokes at 25°C.
Among the ester emollients are: 25
(1) Alkenyl or alkyl esters of fatty acids having 10 to 20 carbon atoms. Examples
thereof include isoarachidyl neopentanoate, isononyl isonanonoate, oleyl myristate,
oleyl stearate and oleyl oleate.
30 (2) Ether-esters such as fatty acid esters of ethoxylated fatty alcohols.
(3) Polyhydric alcohol esters. Ethylene glycol mono- and di-fatty acid esters, diethylene
glycol mono- and di-fatty acid esters, polyethylene glycol (200-6000) mono- and
di-fatty acid esters, propylene glycol mono- and di-fatty acid esters, polypropylene
35 glycol 2000 monooleate, polypropylene glycol 2000 monostearate, ethoxylated
propylene glycol monostearate, glyceryl mono- and di-fatty acid esters, polyglycerol

WO 2007/112855 PCT/EP200 7/002444
-6-
poly-fatty esters, ethoxylated glyceryl monostearate, 1,3-butylene glycol monostearate, 1,3-butylene glycol distearate, polyoxyethylene polyol fatty acid ester, sorbitan fatty acid esters and polyoxyethylene sorbitan fatty acid esters are satisfactory polyhydric alcohol esters. 5
(4) Wax esters such as beeswax, spermaceti, myristyl myristate, stearyl stearate and
arachidyl behenate.
(5) Sterols esters, of which cholesterol fatty acid esters are examples.
10
Fatty acids having from 10 to 30 carbon atoms may also be included as cosmetically acceptable carriers for compositions of this invention. Illustrative of this category are pelargonic, lauric, myristic, palmitic, stearic, isostearic, hydroxystearic, oleic, linoleic, ricinoleic, arachidic, behenic and erucic acids.
15
Humectants of the polyhydric afcohol-type may also be employed as cosmetically acceptable carriers in compositions of this invention. The humectant aids in increasing the effectiveness of the emollient, reduces scaling, stimulates removal of built-up scale and improves skin feel. Typical polyhydric alcohols include glycerol, polyalkylene glycols and
20 more preferably alkylene polyols and their derivatives, including propylene glycol, dipropylene glycol, polypropylene glycol, polyethylene glycol and derivatives thereof, sorbitol, hydroxypropyl sorbitol, hexylene glycol, 1,3-butylene glycol, 1,2,6-hexanetriol, ethoxylated glycerol, propoxylated glycerol and mixtures thereof. For best results the humectant is preferably propylene glycol or sodium hyaluronate. The amount of
25 humectant may range anywhere from 0.5 to 30%, preferably between 1 and 15% by weight of the composition.
Thickeners may also be utilized as part of the cosmetically acceptable carrier of compositions according to the present invention. Typical thickeners include cross-linked
30 acrylates (e.g. Carbopol 982), hydrophobically-modified acrylates (e.g. Carbopol 1382), cellulosic derivatives and natural gums. Among useful cellulosic derivatives are sodium carboxymethyJcellulose, hydroxypropyl methylcellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, ethyl cellulose and hydroxymethyl cellulose. Natural gums suitable for the present invention include guar, xanthan, sclerotium, carrageenan, pectin and
35 combinations of these gums. Amounts of the thickener may range from 0.0001 to 5%, usually from 0.001 to 1%, optimally from 0.01 to 0.5% by weight.

WO 2007/112855 ' ' PCT/EP2007/002444
-7-
Collectively the water, solvents, silicones, esters, fatty acids, humectants and/or thickeners will constitute the cosmetically acceptable carrier in amounts from 1 to 99.9%, preferably from 80 to 99% by weight.
5 An oil or oily material may be present, together with an emulsifier to provide either a water-in-oil emulsion or an oil-in-water emulsion, depending largely on the average hydrophilic-[ipophiflc balance (HLB) of the emulsifier employed.
Surfactants may also be present in cosmetic compositions of the present invention. The
10 \ota\ concentration of the surfactant will range from 0.1 to 40%, preferably from 1 to 20%,
optimally from 1 to 5% by weight of the composition. The surfactant may be selected from
the group consisting of anionic, nonionic, cationic and amphoteric actives. Particularly
preferred nonionic surfactants are those with a C10-C20 fatty alcohol or acid hydrophobe
condensed with from 2 to 100 moles of ethylene oxide or propylene oxide per mole of
15 hydrophobe; C2-C10 alkyl phenols condensed with from 2 to 20 moles of alkyiene oxide;
mono- and di- fatty acid esters of ethylene glycol; fatty acid monoglyceride; sorbitan,
mono- and di- C8-C2o fatty acids; block copolymers (ethylene oxide/propylene oxide); and
polyoxyethylene sorbitan as well as combinations thereof. Alkyl polyglycosides and
saccharide fatty amides (e.g. methyl gluconamides) are also suitable nonionic surfactants.
20 Preferred anionic surfactants include soap, alkyl ether sulfate and sulfonates, alkyl sulfates
and sulfonates, alkylbenzene sulfonates, alkyl and dialkyl sulfosuccinates, C8-C20 acyl
isethionates, acyl glutamates, C8-C20 alkyl ether phosphates and combinations thereof.
OPTIONAL COMPONENTS
25 Other adjunct minor components may also be incorporated into the cosmetic compositions. These ingredients may include coloring agents and/or pigments, opacifiers, perfumes, other thickeners, plasticizers, calamine, antioxidants, chelating agents, as well as additional sunscreens, such as organic sunscreens. The amounts of these other adjunct minor components may range anywhere from 0.001% up to 20% by
30 weight of the composition.
For use as sunscreen, metal oxides may be used alone or in mixture and/or in combination with organic sunscreens. Examples of organic sunscreens include but are not limited those set forth in the table below: 35

WO 2007/112855

PCT/EP2007/002444

-8-
TABLE 1

CTFA Name

Trade Name

Supplier

Benzophenone-1
Benzophenone-2
Benzopbenone-3
Benzophenone-4 10 Benzophenone-6
Benzophenone-8
Benzophenone-12
Methoxycinnamate
Ethyl dihydroxypropyl-PABA 15 Glyceryl PABA
Homosalate
Methyl anthranitate
Octocrylene
Octyl dimethyl PABA 20 Octyl methoxycinnamate
Octyl salicylate
p-Amino benzoic acid (PABA)
2-Phenylbenzimidazole-5-sulphonic
Triethanofamine (TEA) salicylate 25 3-(4-methylbenzylidene)-camphor
4-lsopropyl dibenzoyl methane
Butyl methoxy dibenzoyl methane
Etocrylene

UVINUL 400 UVINUL D-50 UVINUL M-40 UVINUL MS-40 UVINUL D-49 SPECRA-SORB UV-24 UVINUL 408 BERNEL HYDRO AMERSCREEN P NIPAG.M.PA KEMESTER HMS SUNAROME UVA UVINUL N-539 AMERSCOL PARSOL MCX SUNAROMEWMO PABA
acid EUSOLEX 232 SUNAROME W EUSOLEX 6300 EUSOLEX 8020 PARSOL 1789 UVINUL N-35

BASF Chemical Co. BASF Chemical Co. BASF Chemical Co. BASF Chemical Co. BASF Chemical Co. American Cyanamide BASF Chemical Co. Bernel Chemical Amercnol Corp. Nipa Labs. Hunko Chemical Felton Worldwide BASF Chemical Co. Amerchol Corp. Berne! Chemical Felton Worldwide National Starch EM Industries Fefton Worldwide EM Industries EM Industries Givaudan Corp. BASF Chemical Co.

30
The amount of the organic sunscreens in the cosmetic composition is preferably in the range of about 0.1 wt % to about 10 wt %, more preferably about 1 wt % to 5 wt %.
Preferred organic sunscreens are Parsol MCX and Parsol 1789, due to their effectiveness 35 and commercial availability.
USE OF THE COMPOSITION
The method according to the invention is intended primarily as using a personal care product for topical application to human skin, for cosmetic benefits including but not 40 limited to skin lightening.

WO 2007/112855 • • PCT/EP2007/002444
-9-
The inventive compounds and compositions may be used for reducing overall skin pigmentation and the reduction of discrete hyperpigmentation, such as blemishes and freckles, as well as for reducing the irritation associated with irritating skin benefit agents, such as retinol. 5
In use, a small quantity of the composition, for example from 1 to 5 ml, is applied to areas of the skin, from a suitable container or applicator and, if necessary, it is then spread over and/or rubbed into the skin using the hand or fingers or a suitable device.
10 PRODUCT FORM AND PACKAGING
The cosmetic composition useful for the method of the invention can be formulated as a lotion having a viscosity of from 4,000 to 10,000 mPas, a fluid cream having a viscosity of from 10,000 to 20,000 mPas or a cream having a viscosity of from 20,000 to 100,000 mPas or above. The composition can be packaged in a suitable container to suit its
15 viscosity and intended use by the consumer. For example a lotion or fluid cream can be packaged in a bottle or a roll-ball applicator or a propellant-driven aerosol device or a container fitted with a pump suitable for finger operation. When the composition is a cream, it can simply be stored in a non-deformable bottte or squeeze container, such as a tube or a lidded jar. When the composition is a solid or semi-solid stick, it may be
20 packaged in a suitable container for manually or mechanically pushing out or extruding the composition.
The invention accordingly also provides a closed container containing a cosmetically acceptable composition as herein defined. 25
The following examples are by way of example, not by way of limitation, of the principles of the present invention, to illustrate the best mode of carrying out the invention.
EXAMPLE 1 30 Cosmetic compositions within the scope of the invention were prepared. The 4-hydroxyphenylpyruvate was obtained from Sigma-Aldrich.

WO 2007/112855 ' ' PCT/EP2007/002444
-10-
A base formulation shown in the table below was made by heating phase A ingredients to 70 to 85q C with stirring. Phase B ingredients were heated in a separate container to 70 to 85" C with stirring. Then, phase A was added into phase B while both phases were kept at 70 to 85° C. The mixture was stirred for at least 15 minutes at 70 to 85° C, then 5 cooled.

TABLE 2
Ingredients
Isostearyl palmitate
C12-C15 alkyl octanoate
PEG-100stearate
Glyceryl hydroxystearate
Stearyl alcohol
Stearic acid
TEA, 99%
Dimethicone
Sorbitan monostearate
Magnesium aluminum silicate
Vitamin E acetate
Cholesterol
Simethicone
Xanthan gum
Hydroxyethylcellulose
Propylparaben
Disodium EDTA
Butyiated hydroxytolene
4-hydroxyphenylpyntvate
Niacinamide
Metal oxide
Methyiparaben
Water
Total
10 *BAL means Balance.

2a 2b
%wt. 6.00 %wt. 6.00 Phase A
3.00 3.00 A
2.00 2.00 A
1.50 1.50 A
1.50 1.50 A
3.00 4.00 A
1.20 1.20 B
1.00 1.00 A
1.00 1.00 A
0.60 0.60 B
0.10 0.10 A
0.50 0.50 A
0.01 0.01 B
0.20 0.20 B
0.50 0.50 B
0.10 0.10 B
0.05 0.05 B
0.05 0.05 B
0.05 2.00 B
1.00 1.00 B
2.50 5.00 B
0.15 0.15 B
BAL' 100.00 BAL' 100.00 B B

EXAMPLE 2
Additional cosmetic compositions within the scope of the invention were prepared. Both 15 the keto-form and the enol-form of the compounds of the present invention have skin lightening effect.

WO 2007/112855 PCT/EP2007/002444
-11 -
Enol Form
Keto form


5
TABLE 3

Wt% Phase
Water, Dl BALANCE A
Disodium EDTA 0.05 A
Magnesium aluminum silicate 0.6 A
Methyl paraben 0.15 A
Simethicone 0.01 A
Butylene glycol 1,3 3.0 A
Hydroxyethyicellulose 0.5 A
Glycerine, USP 2.0 A
Xanthan gum 0.2 A
Triethanolamine 1.2 B
Stearic acid 3.0 B
Propyl paraben NF 0.1 B

WO 2007/112855 PCT/EP2007/002444
-12-

Glyceryl hydroxystearate 1.5 B
Stearyl alcohol 1.5 B
Isostearyl palmitate 6.0 B
C12-15 alcohols octanoate 3.0 B
Dimethicone 1.0 B
Cholesterol NF 0.5 B
Sorbitan stearate 1.0 B
Micronized titanium dioxide 5.0 C
Tocopheryl acetate 0.1 B
PEG-100 stearate 2.0 B
Sodium stearoyl lactylate 0.5 B
Hydroxycaprylic acid 0.1 C
4-hydroxyphenylpyruvate 10.0 C
Parsol MCX 2.4 C
Alpha-bisabofol 0.2 C
The composition of this example was prepared as follows:
5 1. Heat phase A to 80°C
2. Heat phase B to 75°C in a separate container
3. Add phase B to phase A and mix with heat off for 30 min.
4. At 50°C add phase C and mix for 10 min.
0
EXAMPLES 3-10
A set of additional compositions useful in the methods of the present invention were
prepared within the scope of the present invention and are listed in the table below.

WO 2007/112855 PCT/EP2007/002444
-13-
TABLE 4

Ingredients Phase Examples (weight %)
3
acid soap base 4 5 6 7 8 9 10
Stearic acid A 17.9 17.9 17.9 17.9 17.9 17.9 17.9 17.9
Sodium cetearyl sulfate
(emuls'ifier) A 2.2 1 1.5 2 3 2
Myrj 59 (emulsifier) A 2 2 2 2 2 1
Span 60 (emulsifiers) A 2 2 2 2 2 1
4-hydroxy-phenylpyruvate 8 0.05 0.05 2.0 2.0 3.5 3.5 5.0 10.0
Micronized zinc oxide B 2.50 5.00 5.00 2.50 2.50 5.00 2.50 5.00
KOH, 22% (form in situ soap with stearic acid) 2.20
Octyl methoxycinnamate 2.50 2.50 2.50 2.50
Water B BAL BAL BAL BAL BAL BAL BAL BAL
Glycerin B 1 1 1 1 1 1 1 1
5 EXAMPLE 11
This example shows the skin lightening effect of using 4-hydroxyphenylpyruvate as a skin lightening agent in accordance with the inventive method. This experiment was carried out using MatTek Corporation MelanoDerm cultures. Luminescence was measured using a chromameter to assay the degree of melanizatton of a 3-D skin model.
10
Method for MelanoDerm Cultures
MelanoDerm cultures were obtained from MatTek Corporation, Ashland, Massachusetts. The MelanoDerm was maintained according to the manufacturer's instructions. The basal media used for the maintenance of the MelanoDerm cultures was Dulbecco's
15 Modified Eagle Media (DMEM) supplemented with unspecified quantities of epidermal growth factor, insulin, hydrocortisone, and proprietary epidermal differentiation compounds, in addition to anti-fungal agents and antibiotics.
For the long-term maintenance of the MefanoDerms, the basal media was supplemented 20 with both basic fibroblast growth factor (bFGF) and a-melanocyte-stimulating homone (a-MSH), compounds which are stimulators of melanocyte growth and melanogenesis. The cultures were fed every other day for a total of two weeks. Fresh active preparations, prepared in dimethyl sulphoxide (DMSO) or culture media, were also applied to the

WO 2007/112855 PCT/EP200 7/002444
-14-
MelanoDerms when feeding was performed. Each treatment condition was done in duplicate and digital photographs were taken of the MelanoDerm cultures to assess overall pigmentation. Microscopic images of the MelanoDerms were taken to assess the cell viabifity of the keratinocytes and melanocytes. For further evidence that the 5 treatments were/not cytotoxic, a lactate dehydrogenase (LDH) assay (Promega, Madison, Wl) was performed on the supernatants from 24 hour post-treatment cultures.
Solvable Melanin Assay
To prepare tissues for assay:
10 After treatment, tissues are usually frozen until completion of the experiment. Thaw tissues, a few at a time and place in Dulbecco's phosphated buffer solution (D-PBS) to remove excess phenol red from the culture medium and residual test article. Remove a single tissue from the insert. Blot dry and place in 1.7 ml. microfuge tube. Repeat for all samples. Add 250 ul Solvable™ (Tissue and Gel Solubilizer 0.5 M—Packard
15 BioScience Co. Catalogue No. 6NE9100 (NEF910)). Close the tube and make sure that the tissue is completely submerged. Incubate at 60° C overnight along with standards. In the morning, vortex the samples. Sometimes thick tissues will require additional time to complete the solution process.
20 To prepare standard:
Dissolve melanin (Sigma Catalogue M 8631) in Solvable™ at 1mg/ml. The solution may be warmed gently for 15 minutes at 37° C. Store solution in dark.
To prepare standard curve: 25 Prepare dilutions from the standard containing Oug to 250 ug of melanin in a total of 250
ul Solvable™. Incubate dilutions along with samples.
To read assay:
Cool samples and standards. Centrifuge at 13,000 rpm for 5 minutes to pellet. Fill 30 microwell plate (C-96) with 200 ul each of samples and standards. There is some foaming of samples when pipetted. Blow gently across the samples to break bubbles prior to reading the plate. Read plate at 490nm. The results are shown in the table below.

WO 2007/112855 < PCT/EP2007/002444
-15-
TABLE 5

mg/ml melanin standard OD=490 nm
800 2.727
400 1.321
200 0.573
100 0.321
50 0.184
25 0.065
Controls- OD=490 nm
ETOH 1.035
Untreated 1.259
4-hydroxyphenylpyruvat'e-{uM); OD=.490nn
5 1.236
50 0.687
500 0.565
1000 0.453
From the results tabulated above it appears that 4-hydroxyphenylpyruvate compounds of the present invention reduce melanin synthesis.
It should be understood that the specific forms of the invention herein illustrated and 10 described are intended to be representative only. Changes, including but not limited to those suggested in this specification, may be made in the illustrated embodiments without departing from the clear teachings of the disclosure. Accordingly, reference should be made to the following appended claims in determining the full scope of the invention. Throughout this application, various publications have been cited. The entireties of each 15 of these publications are hereby incorporated by reference herein.

WO 2007/112855 ■ PCT/EP2007/002444
-16-
CLAIMS
1. A cosmetic method of skin lightening comprising applying to the skin a
5 composition comprising:
a. 0.000001 to 50 % of a compound of general formula 1, II, or mixtures thereof:
(I)

15
2.

wherein each R, independently, represents a hydrogen atom, C1-C4 acyl group, or C1-C4 alkyl group; and b. a cosmetically acceptable carrier.
The cosmetic method of claim 1, wherein said compound is selected from the group consisting of compound of formula IA, compound of formula IIA, and mixtures thereof:

WO 2007/112855

PCT/EP2007/002444

-17-

(IA)

(HA)
3. The cosmetic method of claim 1, wherein at least one R represents hydrogen.
4. The cosmetic method of claim 1, wherein said composition further comprises a sunscreen.
5. The cosmetic method of claim 4, wherein said sunscreen is a micronized metal oxide.
6. The cosmetic method of claim 1, wherein said composition further comprises a skin benefit agent selected from the group consisting of aipha-hydroxy acids, beta-hydroxy acids, polyhydroxy acids, betuiinic acid, hyaluronic acid, hydroquinone, t-butyl hydroquinone, vitamin C derivatives, dioic acids, retinoids, resorcinol derivatives and mixtures thereof.

WO 2007/112855

PCT/EP2007/002444

-18-

10

8.

The cosmetic method of claim 1, wherein said composition further comprises an
organic sunscreen selected from the group consisting of benzophenone-3,
benzophenone-4, benzophenone-8, DEA methoxycinnamate, ethyl
dihydroxypropyl-PABA, glyceryl PABA, homosalate, methyl anthranilate,
octocrylene, octyl dimethyl PABA, octyl methoxycinnamate (Parsol MCX), octyl
salicylate, PABA, 2-phenylbenzimidazole-5-su[phonic acid, TEA salicylate, 3-(4-
methylbenzylidene)-camphor, benzophenone-1, benzophenone-2,
benzophenone-6, benzophenone-12, 4-isopropyl dibenzoylmethane, butyl methoxydibenzoylmethane (Parsol 1789), etocrylene and mixtures thereof.
A cosmetic composition comprising:
a. 0.000001 to 50 % of a compound of general formula I, II, or mixtures thereof:

15

R-O

20

wherein each R, independently, represents a hydrogen atom, C1-C4, acyl group, or C1-C4 alkyl group; and b. a cosmetically acceptable carrier.

WO 2007/112855

PCTEP2007/002444

-19-
9. The cosmetic composition of claim 8, wherein said compound is selected from the group consisting of compound of formula IA, compound of formula IIA, and mixtures thereof:

(IA)
HO


10

10. The cosmetic composition of claim 9, wherein said compound comprises 0.00001% to 10 % of said composition.
11. The cosmetic composition of claim 9, wherein said compound comprises 0.001 % to 7 % of said composition.

15

12. The cosmetic composition of claim 9, wherein said compound comprises 0.01 % to 5 % of said composition.

13. A cosmetic composition for skin lightening, comprising:
a. 0.000001 to 50 % of a compound of general formula I, II, or mixtures thereof:

WO 2007/112855

PCT/EP2007/002444

-20-



(1!)
wherein each R, independently, represents a hydrogen atom, C1-C4 acyl group, or C1-C4 alkyl group; and b. a cosmetically acceptable carrier.
Dated this 25th day of September 2008
HINDUSTAN UNILEVER LIMITED

(S. Venkatramani) Senior Patents Manager